Scientists Turn to Chewing Gum in the Fight Against Oral Cancer

senior woman blowing bubble with pink chewing gum

A familiar habit like chewing gum might one day play a surprising role in the fight against cancer. Researchers at the University of Pennsylvania have developed a plant-based, cancer-fighting chewing gum that sharply reduced levels of cancer-linked microbes in laboratory tests. In oral samples from patients with head and neck cancer, extracts from this gum cut human papillomavirus (HPV) levels by up to 93 percent and nearly eliminated two harmful bacterial species. Even more notable, the gum appeared to spare beneficial bacteria in the mouth, a result that has caught the attention of scientists exploring new ways to prevent or support treatment for cancer.

Head and neck squamous cell carcinoma, often abbreviated as HNSCC, is a common and challenging form of cancer that begins in the thin, flat squamous cells lining the mouth and throat. These cancers are often difficult to treat, particularly once they spread beyond their original site. Many patients diagnosed at advanced stages still face poor five-year survival outcomes despite modern therapies. The study’s lead researcher, Henry Daniell of the University of Pennsylvania’s School of Dental Medicine, highlighted that even recently approved anticancer drugs have not dramatically improved survival or quality of life for many of these patients. This sobering reality has pushed scientists to look beyond traditional treatments and consider how infection control and the oral microbiome might influence cancer risk and recovery.

Among the microbes under scrutiny, HPV stands out. It is a very common virus, and persistent infections with certain types are linked to several cancers, including oropharyngeal cancer that affects parts of the throat such as the tonsils and the base of the tongue. At the same time, researchers have been examining the role of specific bacteria in cancer outcomes. Two species in particular, Porphyromonas gingivalis (Pg) and Fusobacterium nucleatum (Fn), are associated with oral disease and have been linked to poorer survival in patients with untreated recurrent or metastatic oral cancers. The study notes that infections with Pg and Fn can worsen survival rates even in patients who have undergone surgery and received risk-adjusted adjuvant therapies intended to improve outcomes.

The new work, published in Scientific Reports, centers on a novel way to deliver therapeutic proteins to the mouth: cancer-fighting chewing gum derived from lablab beans. Daniell’s team has spent years developing ways to use specially engineered plants to produce proteins with medical potential. In this case, the gum features a naturally occurring antiviral protein called FRIL. To see how well this approach might work, the researchers collected saliva and oral rinse samples from patients with head and neck cancer and exposed these samples to extracts of the bean-based gum in the laboratory.

Close-up of a chewing pad in the hand of a man

The results were striking. In saliva samples, gum extracts reduced HPV levels by 93 percent, and in oral rinse samples the reduction was 80 percent. These findings suggest that proteins released while chewing gum could significantly lower HPV levels in the mouth. I found this detail striking because HPV-associated oropharyngeal cancers have been increasing worldwide, and any approach that safely reduces viral load in the oral cavity could be a promising adjunct to current preventive strategies such as vaccination and safe practices.

The researchers did not stop at antiviral activity alone. They enhanced the gum by adding protegrin, an antimicrobial peptide. Peptides are short chains of amino acids, and some antimicrobial peptides can directly damage or destroy harmful microbes. With protegrin incorporated, the engineered gum showed powerful antibacterial activity in the ex vivo tests. A single dose of the gum extract reduced Porphyromonas gingivalis and Fusobacterium nucleatum to nearly undetectable levels in the patient samples. This dual action against both a cancer-linked virus and cancer-associated bacteria is part of what makes this cancer-fighting chewing gum so intriguing to the research community.

Equally important is what the gum did not do. The oral cavity hosts a complex and diverse microbiome that contributes to oral and overall health. Many microbes in the mouth help maintain a stable, protective environment. Cancer treatments such as radiation therapy can upset this balance, lowering beneficial bacterial populations while giving an advantage to opportunistic organisms like Candida albicans. In contrast, the experimental gum extracts sharply diminished the targeted harmful bacteria without disrupting the beneficial bacterial groups the researchers examined. This selectivity suggests a therapeutic window in which infections can be addressed without causing broad collateral damage to the oral microbiome.

At the same time, the scientists emphasize that these were ex vivo studies. The gum itself was not chewed by patients in a clinical setting. Instead, the experiments exposed patient saliva and oral rinse samples to gum extracts in the laboratory. While the reductions in HPV and cancer-associated bacteria are impressive, future clinical trials will be necessary to learn whether similar effects occur in actual mouths, how long any benefits might last, and whether such microbial changes translate into better cancer prevention, fewer recurrences, or improved responses to therapy.

Despite those important caveats, the findings suggest multiple potential roles for this technology. One possibility is using such gum as an adjuvant therapy, complementing existing cancer treatments by helping to control harmful microbes during and after care. Another is prophylactic use, where people at elevated risk of oral infections or cancer might one day use the gum to help limit exposure to certain viruses and bacteria or reduce their levels. The study points out that lip and oral cavity cancer ranked among the top cancer types worldwide in incidence and mortality in adolescents, young adults, and middle-aged adults in 2022. That context underscores the global importance of exploring affordable and practical tools such as plant-based therapeutics and microbiome-friendly interventions.

The gum’s plant-based production system could also carry practical benefits. Because the therapeutic proteins are manufactured in engineered plants, there is potential for scalable and cost-conscious production, which might be especially important in regions where access to advanced cancer therapies is limited. While cost and access considerations are not fully resolved by a single study, the approach hints at the possibility of relatively simple delivery formats that can be integrated into daily routines, such as chewing a piece of gum.

For now, though, this cancer-fighting chewing gum remains an experimental concept supported by promising laboratory data rather than human trials. There is no evidence yet that it can directly prevent or treat cancer in people. What the study does offer is a compelling proof of principle that targeted antiviral and antibacterial proteins delivered through something as commonplace as chewing gum may meaningfully alter levels of cancer-associated microbes in the mouth. As research progresses, clinical studies will need to evaluate safety, dosing, long-term impact on the oral microbiome, and real-world benefits for cancer prevention and treatment.

Read more at https://penntoday.upenn.edu/news/penn-dental-medicine-fighting-oral-cancer-bioengineered-chewing-gum

Back to blog
Customers Also Viewed

Beat the Rush, Shop Now for
the Best Selection

Recommended Just For You
Recently Viewed & Trending Items
DEV MODE ACTIVE. BRAND: gg